<- Go Home

Indegene Limited

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Market Cap

INR 127.6B

Volume

792.7K

Cash and Equivalents

INR 4.9B

EBITDA

INR 5.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

INR 29.8B

Profit Margin

97.95%

52 Week High

INR 681.70

52 Week Low

INR 499.00

Dividend

0.38%

Price / Book Value

4.45

Price / Earnings

28.74

Price / Tangible Book Value

5.52

Enterprise Value

INR 116.1B

Enterprise Value / EBITDA

20.19

Operating Income

INR 4.9B

Return on Equity

17.06%

Return on Assets

9.27

Cash and Short Term Investments

INR 12.7B

Debt

INR 1.2B

Equity

INR 28.7B

Revenue

INR 30.4B

Unlevered FCF

-INR 2.3B

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches